233 related articles for article (PubMed ID: 18211987)
1. A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.
Morizane C
Jpn J Clin Oncol; 2007 Dec; 37(12):973. PubMed ID: 18211987
[No Abstract] [Full Text] [Related]
2. Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.
Kawashima H; Itoh A; Ohno E; Nakamura M; Miyahara R; Ohmiya N; Hara K; Kanamori A; Itoh T; Taki T; Hirai T; Hashimoto S; Takeda K; Goto H; Hirooka Y
Cancer Chemother Pharmacol; 2011 Sep; 68(3):677-83. PubMed ID: 21132496
[TBL] [Abstract][Full Text] [Related]
3. [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Ohara T; Fujino Y; Goto H; Yamashita H; Oyama M; Katsura M; Sugiyama H; Ueda Y; Hasegawa H; Yasuda T; Kakinoki K; Oshikiri T; Sendo H; Sugimoto T; Tominaga M
Gan To Kagaku Ryoho; 2015 May; 42(5):633-5. PubMed ID: 25981662
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].
Omori K; Wakabayashi K; Suematsu Y; Suda H; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1582-4. PubMed ID: 26805103
[TBL] [Abstract][Full Text] [Related]
5. Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan.
Nakai Y; Isayama H; Sasaki T; Sasahira N; Kogure H; Hirano K; Tsujino T; Ijichi H; Tateishi K; Tada M; Omata M; Koike K
Jpn J Clin Oncol; 2010 Aug; 40(8):774-80. PubMed ID: 20462979
[TBL] [Abstract][Full Text] [Related]
6. S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.
Todaka A; Fukutomi A; Boku N; Onozawa Y; Hironaka S; Yasui H; Yamazaki K; Taku K; Machida N; Sakamoto T; Tomita H
Jpn J Clin Oncol; 2010 Jun; 40(6):567-72. PubMed ID: 20189975
[TBL] [Abstract][Full Text] [Related]
7. [The progress of chemotherapy for advanced pancreatic cancer].
Ioka T; Katayama K; Ashida R; Takahashi H; Teshima T; Sakon M
Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2119-26. PubMed ID: 26638783
[No Abstract] [Full Text] [Related]
8. [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].
Fujimoto C; Maruyama Y; Niina Y; Fujimori N; Sumii T; Funakoshi A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):1013-6. PubMed ID: 18633236
[TBL] [Abstract][Full Text] [Related]
9. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.
Ueno M; Okusaka T; Omuro Y; Isayama H; Fukutomi A; Ikeda M; Mizuno N; Fukuzawa K; Furukawa M; Iguchi H; Sugimori K; Furuse J; Shimada K; Ioka T; Nakamori S; Baba H; Komatsu Y; Takeuchi M; Hyodo I; Boku N
Ann Oncol; 2016 Mar; 27(3):502-8. PubMed ID: 26681680
[TBL] [Abstract][Full Text] [Related]
11. Modified FOLFIRINOX for Locally Advanced and Metastatic Pancreatic Cancer Patients Resistant to Gemcitabine and S-1 in Japan: A Single Institutional Experience.
Umemura A; Nitta H; Sasaki A; Takahara T; Hasegawa Y; Wakabayashi G
Hepatogastroenterology; 2014 May; 61(131):814-20. PubMed ID: 26176079
[TBL] [Abstract][Full Text] [Related]
12. [A case of pancreatic cancer treated by gemcitabine with sequential radiotherapy].
Hisama S; Kimura M; Nishimura T; Matsushita H; Okamura S; Saitoh S; Shimokawa Y; Arakawa A; Toyama H; Tanaka Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1337-9. PubMed ID: 20647722
[TBL] [Abstract][Full Text] [Related]
13. Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Ohge H; Sueda T
J Gastrointest Surg; 2009 Jan; 13(1):85-92. PubMed ID: 18704593
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
Li Y; Sun J; Jiang Z; Zhang L; Liu G
J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer.
Sudo K; Yamaguchi T; Nakamura K; Denda T; Hara T; Ishihara T; Yokosuka O
Cancer Chemother Pharmacol; 2011 Feb; 67(2):249-54. PubMed ID: 20352216
[TBL] [Abstract][Full Text] [Related]
16. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
[TBL] [Abstract][Full Text] [Related]
17. [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Tokairin Y; Iida M; Yamazaki S
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2123-5. PubMed ID: 19106544
[TBL] [Abstract][Full Text] [Related]
18. Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.
Seki Y; Okusaka T; Ikeda M; Morizane C; Ueno H
Jpn J Clin Oncol; 2009 Nov; 39(11):751-5. PubMed ID: 19666905
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of and therapy for pancreatic neoplasms].
Motoo Y
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):818-21. PubMed ID: 17506324
[No Abstract] [Full Text] [Related]
20. Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1.
Kurihara T; Kogo M; Ishii M; Yoneyama K; Kitamura K; Shimada K; Shimizu S; Yoshida H; Kiuchi Y
Hepatogastroenterology; 2015; 62(138):478-84. PubMed ID: 25916086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
